The results of the SURPASS-2 clinical trial evaluating the effects of tirzepatide in patients with type 2 diabetes showed that the trial treatment resulted...
TipRanksJPMorgan says these 2 stocks could rise over 80%After a volatile first quarter, the second quarter has started in style and major indices are...